Abstract
Wake-up stroke (WUS) patients are typically excluded from reperfusion treatment, as the time of symptoms onset is unknown. The purpose of this study is to evaluate the clinical outcome and safety of intravenous thrombolysis with rt-PA in patients with WUS eligible for therapy using computed tomography perfusion criteria (CTP), compared to patients treated with rt-PA within 4.5 h of symptoms onset (non-WUS). This is an experimental, open-label trial, controlled against the best therapy currently in use. Primary endpoints were functional independence after 3 months [modified Rankin scale (mRS) ≤ 1] for clinical outcome and symptomatic intracerebral hemorrhage (SICH) for safety. Secondary endpoints were no or only mild disability after 3 months (mRS ≤2) for clinical outcome, total intracerebral hemorrhage (TICH) and contrast-induced nephropathy (CIN) for safety. 170 patients were treated, 143 non-WUS patients and 27 patients with WUS. Strokes of cardioembolic origin were most common in WUS patients (p < 0.001). Primary endpoints: mRS ≤1 was found in 35.8 % (non-WUS: 36.4 % vs. WUS 33.3 %; p = 0.62) and SICH was observed in 3.4 % of non-WUS patients and in WUS patients (p = 0.32). Secondary endpoints: mRS ≤2 was observed in 66.4 % of patients (non-WUS: 67.1 % vs. WUS 62.9 %; p = 0.67), TICH in 13.5 % of patients (13.9 % non-WUS vs. 11.1 % WUS; p = 0.69). CIN was documented in 3.7 % of WUS patients. rt-PA treatment carried out in WUS patients selected on the basis of CTP data demonstrate comparable clinical outcome and safety with respect to non-WUS patients. The study supports the hypothesis that a selected group of WUS patients may be suitable for thrombolysis.

Similar content being viewed by others
References
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al (2008) ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329
Campbell BC, Donnan GA, Lees KR, Hacke W, Khatri P, Hill MD et al (2015) Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol Jun 25. pii: S1474-4422(15)00140-4. doi: 10.1016/S1474-4422(15)00140-4
Kang DW, Kwon JY, Kwon SU, Kim JS (2012) Wake-up or unclear-onset strokes: are they waking up to the world of thrombolysis therapy? Int J Stroke 7:311–320
González RG (2006) Imaging-guided acute ischemic stroke therapy: from “time is brain” to “physiology is brain”. AJNR Am J Neuroradiol 27:728–735
Bivard A, Spratt N, Levi CR, Parsons MW (2011) Acute stroke thrombolysis: time to dispense with the clock and move to tissue-based decision making? Expert Rev. Cardiovasc Ther 9:451–461
Heiss WD (2011) The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. Cerebrovasc Dis 32:307–320
Quinn TJ, Dawson J, Walters M (2008) Dr. John Rankin; his life, legacy and the 50th anniversary of the Rankin stroke scale. Scott Med J 53:44–47
Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R (2013) Contrast-induced nephropathy. Heart Views 14:106–116
Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME et al (2001) Use of the alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 22:1534–1542
Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E et al (1999) Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 30:2280–2284
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245–1251
Serena J, Davalos A, Segura T, Mostacero E, Castillo J (2003) Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 16:128–133
Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H (2006) Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 21:367–371
Silva GS, Lima FO, Camargo EC, Smith WS, Singhal AB, Greer DM et al (2010) Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis 29:336–342
Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG et al (2008) Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 25:572–579
Kang DW, Sohn SI, Hong KS, Yu KH, Hwang YH, Han MK et al (2012) Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study. Stroke 43:3278–3283
Kim JT, Park MS, Nam TS, Choi SM, Kim BC, Kim MK et al (2011) Thrombolysis as a factor associated with favorable outcomes in patients with unclear-onset stroke. Eur J Neurol 18:988–994
Aoki J, Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Watanabe M et al (2011) Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis 31:435–441
Adams HP Jr, Leira EC, Torner JC, Barnathan E, Padgett L, Effron MB et al (2008) Treating patients with ‘wake-up’ stroke: the experience of the AbESTT-II trial. Stroke 39:3277–3282
Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR et al (2009) Thrombolytic therapy for patients who wake-up with stroke. Stroke 40:827–832
Cortijo E, García-Bermejo P, Calleja AI, Pérez-Fernández S, Gómez R, del Monte JM et al (2014) Intravenous thrombolysis in ischemic stroke with unknown onset using CT perfusion. Acta Neurol Scand 129:178–183
García-Bermejo P, Calleja AI, Pérez-Fernández S, Cortijo E, del Monte JM, García-Porrero M et al (2012) Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. Cerebrovasc Dis 34:31–37
Konstas AA, Wintermark M, Lev MH (2011) CT perfusion imaging in acute stroke. Neuroimaging Clin N Am 21:215–238
Nael K, Khan R, Choudhary G, Meshksar A, Villablanca P, Tay J et al (2014) Six-minute magnetic resonance imaging protocol for evaluation of acute ischemic stroke: pushing the boundaries. Stroke 45:1985–1991
Riccio PM, Klein FR, Pagani Cassará F, Muñoz Giacomelli F, González Toledo ME, Racosta JM, Delfitto M et al (2013) Newly diagnosed atrial fibrillation linked to wake-up stroke and TIA. Neurology 80:1834–1840
Deguchi Y, Amino M, Adachi K et al (2009) Circadian distribution of paroxysmal atrial fibrillation in patients with and without structural heart disease in untreated state. Ann Noninvasive Electrocardiol 14:280–289
Krol AL, Dzialowski I, Roy J, Puetz V, Subramaniam S, Coutts SB et al (2007) Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke 38:2364–2366
Dittrich R, Akdeniz S, Kloska SP, Fischer T, Ritter MA, Seidensticker P et al (2007) Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients. J Neurol 254:1491–1497
Goyal M, Menon BK, Derdeyn CP (2013) Perfusion imaging in acute ischemic stroke: let us improve the science before changing clinical practice. Radiology 266:16–21
Fisher M, Albers GW (2013) Advanced imaging to extend the therapeutic time window of acute ischemic stroke. Ann Neurol 73:4–9
Kane I, Sandercock P, Wardlaw J (2007) Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 78:485–491
Kucinski T, Naumann D, Knab R, Schoder V, Wegener S, Fiehler J et al (2005) Tissue at risk is overestimated in perfusion weighted imaging: mR imaging in acute stroke patients without vessel recanalization. AJNR Am J Neuroradiol 26:815–819
Morelli N, Morelli J, Rota E, Michieletti E, Guidetti D (2013) CT perfusion mismatch in subacute stroke: oligemia or luxury perfusion? CNS Neurosci Ther 19:914–915
MR WITNESS: a study of intravenous thrombolysis with alteplase in MRI-selected patients. Clinicaltrials.org—a service of the US National Institutes of Health Promotion web site. http://clinicaltrials.gov/ct2/show/NCT01282242. Accessed 14 Mar 2015
Safety may be of intravenous thrombolysis for wake-up stroke (wake-up stroke). Clinicaltrials.org—a service of the US National Institutes of Health Promotion web site. http://www.clinicaltrials.gov/ct2/show/NCT01183533. Accessed 14 Mar 2015
Extending the time for thrombolysis in emergency neurological deficits (EXTEND trial). Clinicaltrials.org—a service of the US National Institutes of Health Promotion web site. http://clinicaltrials.gov/show/NCT00887328. Accessed 14 Mar, 2015
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Statement of human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Morelli, N., Rota, E., Immovilli, P. et al. Computed tomography perfusion-based thrombolysis in wake-up stroke. Intern Emerg Med 10, 977–984 (2015). https://doi.org/10.1007/s11739-015-1299-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-015-1299-0